Showing results (411-420 of 785) with videos related to
Sort By:
Pageof 79
The Lancet. HIV|May 2, 2025
Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular diseaseJasmini Alagaratnam, Kathrin van Bremen, Georg M N Behrens, et al.The Lancet. HIV|May 4, 2025
Lateral flow assay-based CD4 cell count testing for advanced HIV diseaseZibusiso Ndlovu, Ana Moore, Esther C Casas, et al.The Lancet. HIV|May 29, 2025
Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trialKelly E Seaton, Carmen A Paez, Chenchen Yu, et al.The Lancet. HIV|June 5, 2025
Magnitude and characteristics of unsuppressed HIV viral load in children and adolescents on antiretroviral therapy in sub-Saharan Africa: a systematic review and meta-analysisOlivier Mukuku, Kaymarlin Govender, Stanislas Okitotsho Wembonyama, et al.The Lancet. HIV|June 7, 2025
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysisCarl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, et al.The Lancet. HIV|February 9, 2026
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trialJayne Ellis, Gila Hale, Laura J Nsangi, et al.The Lancet. HIV|March 27, 2025
Tuberculosis disease among people with HIV: therapeutic advancesVidya Mave, Mandar Paradkar, Francesca Conradie, et al.The Lancet. HIV|November 28, 2017
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling studyAndrew N Phillips, Valentina Cambiano, Fumiyo Nakagawa, et al.The Lancet. HIV|December 4, 2018
Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling studyAndrew N Phillips, Francois Venter, Diane Havlir, et al.The Lancet. HIV|December 19, 2018
Elimination of HIV transmission through novel and established prevention strategies among people who inject drugsHudson Reddon, Brandon D L Marshall, M-J MilloyPageof 79